RecruitingNCT03267615

VICIS - Vienna Cirrhosis Study

Sponsor

Medical University of Vienna

Enrollment

10,000 participants

Start Date

Feb 1, 2017

Study Type

OBSERVATIONAL

Conditions

Ascites Liver Cirrhosis Portal Hypertension Hepatic Encephalopathy Variceal Hemorrhage

Summary

Patients with advanced chronic liver diseases treated at the Vienna General Hospital of the Medical University of Vienna will be offered to participate in this prospective observational trial - including an optional participation in a biobank. Clinical parameters and laboratory parameters will be recorded for all patients and patients will undergo a regular follow-up schedule with clinical visits at the Vienna General Hospital. This study is linked to a biobank with serum/plasma, ascitic fluid, urine, GI tract mucosal biopsies, liver biopsies and stool collected from the study participants.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This is a long-term observational study (registry) in Vienna, Austria that is following patients with advanced chronic liver disease (cirrhosis) to better understand how the disease progresses and what factors affect outcomes over time. **You may be eligible if...** - You are between 18 and 100 years old - You have been diagnosed with advanced chronic liver disease (cirrhosis), confirmed by liver stiffness measurement, pressure measurement, or biopsy showing significant scarring - You are willing to provide written consent **You may NOT be eligible if...** - You withdraw your consent to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.